By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie (AERI) Reports Third Quarter 2016 Financial Results And Provides Business Update 11/3/2016 11:49:10 AM
Aerie (AERI) Reports Positive Topline Efficacy Results Of Rocket 4 Phase 3 Trial Of Rhopressatm (Netarsudil Ophthalmic Solution) 0.02% 10/28/2016 9:59:36 AM
Aerie (AERI) To Host Investor Day On October 5, 2016 9/28/2016 11:49:29 AM
Aerie (AERI) Raises $125 Million In Public Offerings 9/16/2016 11:30:01 AM
Aerie (AERI) Announces Public Offering Of Common Stock 9/16/2016 10:57:45 AM
Fresh Off Its Positive Phase III, Aerie (AERI) Quickly Nabs $125 Million in Public Offerings 9/16/2016 6:30:31 AM
SoCal's Aerie (AERI) Stock Soars Over the Rainbow on Positive Phase III Eye Drug Data 9/15/2016 7:40:35 AM
Aerie (AERI) Submits New Drug Application To U.S. FDA For Rhopressa (Netarsudil Ophthalmic Solution) 0.02% 9/7/2016 12:58:31 PM
Aerie (AERI) To Present At The Canaccord Genuity Growth Conference 8/4/2016 12:14:11 PM
Aerie (AERI) Reports Second Quarter 2016 Financial Results And Provides Business Update 8/4/2016 10:48:14 AM
12345678910...
//-->